Search research articles
Contact Us
Filters
Showing results (11-20 of 155) with videos related to
Page
of 16
Sort By:
BMC Neurology
|
July 10, 2024
Correction: Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries"
Harmen R Moes, Erik Buskens, Teus van Laar
The Lancet. Neurology
|
August 16, 2024
Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease
Harmen R Moes, Erik Buskens, Teus van Laar
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 27, 2007
Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism
Anna-Gerlind Postma, Mart Heesters, Teus van Laar
Parkinsonism & Related Disorders
|
April 7, 2022
Letter to the editor, "Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications"
Harmen R Moes, Erik Buskens, Teus van Laar
Parkinsonism & Related Disorders
|
June 16, 2009
Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations
Teus van Laar, Anna G Postma, Martje Drent
Annals of Neurology
|
August 27, 2025
Reply to From Topography to Therapy: Rethinking Cognitive Monitoring in GBA1-Linked PD
Sofie Slingerland, Sygrid van der Zee, Teus van Laar
Parkinsonism & Related Disorders
|
December 29, 2015
Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients
Robbert W K Borgemeester, Martje Drent, Teus van Laar
Parkinsonism & Related Disorders
|
May 2, 2016
Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
Robbert W K Borgemeester, Andrew J Lees, Teus van Laar
NPJ Parkinson'S Disease
|
June 26, 2024
A retrospective study of the MDS criteria for prodromal Parkinson's disease in the general population
Gijs W de Klerk, Teus van Laar, Sanne K Meles
Nederlands Tijdschrift Voor Geneeskunde
|
October 28, 2010
[Rasagiline is not for all Parkinson disease patients: the ADAGIO study]
Teus van Laar, Agnita J W Boon, Bastiaan R Bloem
Page
of 16
Search research articles
Search
Showing results (11-20 of 155) with videos related to
Sort By:
Page
of 16
BMC Neurology
|
July 10, 2024
Correction: Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries"
Harmen R Moes, Erik Buskens, Teus van Laar
The Lancet. Neurology
|
August 16, 2024
Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease
Harmen R Moes, Erik Buskens, Teus van Laar
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 27, 2007
Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism
Anna-Gerlind Postma, Mart Heesters, Teus van Laar
Parkinsonism & Related Disorders
|
April 7, 2022
Letter to the editor, "Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications"
Harmen R Moes, Erik Buskens, Teus van Laar
Parkinsonism & Related Disorders
|
June 16, 2009
Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations
Teus van Laar, Anna G Postma, Martje Drent
Annals of Neurology
|
August 27, 2025
Reply to From Topography to Therapy: Rethinking Cognitive Monitoring in GBA1-Linked PD
Sofie Slingerland, Sygrid van der Zee, Teus van Laar
Parkinsonism & Related Disorders
|
December 29, 2015
Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients
Robbert W K Borgemeester, Martje Drent, Teus van Laar
Parkinsonism & Related Disorders
|
May 2, 2016
Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
Robbert W K Borgemeester, Andrew J Lees, Teus van Laar
NPJ Parkinson'S Disease
|
June 26, 2024
A retrospective study of the MDS criteria for prodromal Parkinson's disease in the general population
Gijs W de Klerk, Teus van Laar, Sanne K Meles
Nederlands Tijdschrift Voor Geneeskunde
|
October 28, 2010
[Rasagiline is not for all Parkinson disease patients: the ADAGIO study]
Teus van Laar, Agnita J W Boon, Bastiaan R Bloem
Page
of 16